Related Experiment Video

Updated: Oct 8, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.6K

NLRP2 inhibits cell proliferation and migration by regulating EMT in lung adenocarcinoma cells

Tiantian Li1, Xu Li1, Rongchen Mao1

  • 1Department of Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, China.

Cell Biology International
|December 27, 2021
PubMed

Insights

Nucleotide-binding oligomerization domain-like receptors (NLRs), specifically NLRP2, act as an antioncogene in lung adenocarcinoma. NLRP2 inhibits cancer cell proliferation and metastasis by regulating epithelial-to-mesenchymal transition (EMT).

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Nucleotide-binding oligomerization domain-like receptors (NLRs) are key innate immune sensors.
  • The role of NLRP2 in cancer progression, particularly lung adenocarcinoma (LUAD), remains largely unexplored.

Purpose of the Study:

  • To investigate the function of NLRP2 in lung adenocarcinoma.
  • To determine if NLRP2 acts as an antioncogene or oncogene in LUAD.

Main Methods:

  • Utilized gain- and loss-of-function studies in LUAD cells.
  • Investigated the impact of NLRP2 on NF-kB signaling, epithelial-to-mesenchymal transition (EMT), cytoskeleton reorganization, and cofilin phosphorylation.
  • Conducted in vivo studies to assess metastasis formation.

Main Results:

  • NLRP2 was identified as an antioncogene in LUAD.
  • NLRP2 silencing promoted proliferation and migration by activating NF-kB signaling, inducing EMT, and altering cytoskeleton organization.
  • NLRP2 increased cofilin phosphorylation, inhibiting F-actin reorganization and metastasis formation in vivo.

Conclusions:

  • NLRP2 functions as a tumor suppressor in lung adenocarcinoma.
  • NLRP2 inhibits LUAD cell proliferation and migration by suppressing EMT and metastasis.
  • NLRP2 plays a critical role in regulating LUAD development.
Keywords:
F-actinNLRP2cell proliferation and migrationp-cofilinvimentin

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.1K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K